Video Experimental Relacionado
Updated: Jun 7, 2026
08:04
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Las señales Ras, PI(3)K y mTOR controlan el crecimiento de las células tumorales
Reuben J Shaw1, Lewis C Cantley
1Dulbecco Laboratory for Cancer Research, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, California 9203, USA. shaw@salk.edu
Nature
|May 26, 2006
Resumen
Las células eucariotas vinculan el crecimiento con la disponibilidad de nutrientes a través de la señalización mTOR. Las mutaciones en las vías Ras y PI(3)K, cruciales para este proceso, son comunes en los cánceres, lo que sugiere un papel en el desarrollo del tumor.
Área de la Ciencia:
- Biología celular Biología celular.
- Biología Molecular Biología Molecular
- Biología del cáncer Biología del cáncer.
Sus antecedentes:
- Las células eucariotas deben coordinar el crecimiento con los niveles de nutrientes ambientales.
- La proteína quinasa mTOR actúa como un regulador central del crecimiento celular.
- mTOR integra las señales de los factores de crecimiento (a través de Ras y PI) y la disponibilidad de nutrientes (aminoácidos, glucosa, oxígeno).
Objetivo del estudio:
- Para resaltar el papel crítico de mTOR en la vinculación del crecimiento celular a la disponibilidad de nutrientes.
- Para enfatizar la importancia de las vías de señalización Ras y PI ((3) K en el control del crecimiento.
- Proponer que la desregulación de estas vías contribuye a la tumorigénesis.
Principales métodos:
- Revisión de las vías de señalización involucradas en la regulación del crecimiento celular.
- Análisis de mutaciones en cánceres humanos.
- Integración de datos sobre detección de nutrientes y control del crecimiento celular.
Principales resultados:
- mTOR es un nodo clave que integra los factores de crecimiento y las señales de nutrientes.
- Los componentes de las vías Ras y PI(3)K con frecuencia sufren mutaciones en los cánceres humanos.
- Estas mutaciones interrumpen los puntos de control de control de crecimiento.
Conclusiones:
- La pérdida de puntos de control de control de crecimiento y la mejora de la supervivencia celular bajo limitación de nutrientes son probablemente esenciales para el desarrollo del cáncer.
- La interconexión de las vías Ras, PI(3)K y mTOR subraya su importancia en la tumorigénesis.
- Comprender estas vías es crucial para la investigación del cáncer y las estrategias terapéuticas.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...